This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1svz

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1svz" size="450" color="white" frame="true" align="right" spinBox="true" caption="1svz, resolution 1.89&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1svz.gif|left|200px]]<br />
+
[[Image:1svz.gif|left|200px]]<br /><applet load="1svz" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1svz" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1svz, resolution 1.89&Aring;" />
caption="1svz, resolution 1.89&Aring;" />
'''Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-2 protease'''<br />
'''Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-2 protease'''<br />
==Overview==
==Overview==
-
The monoclonal antibody 1696, elicited by HIV-1 protease, inhibits the, activity of both HIV-1 and HIV-2 proteases with inhibition constants in, the low nanomolar range. The antibody cross-reacts with peptides derived, from the N-terminal region of both proteases. The crystal structure of the, recombinant single-chain Fv fragment of 1696 complexed with an N-terminal, peptide from the HIV-2 protease has been determined at 1.88A resolution., Interactions of the peptide with scFv1696 are compared with the previously, reported structure of scFv1696 in complex with the corresponding peptide, from HIV-1 protease. The origin of cross-reactivity of mAb1696 with HIV, proteases is discussed.
+
The monoclonal antibody 1696, elicited by HIV-1 protease, inhibits the activity of both HIV-1 and HIV-2 proteases with inhibition constants in the low nanomolar range. The antibody cross-reacts with peptides derived from the N-terminal region of both proteases. The crystal structure of the recombinant single-chain Fv fragment of 1696 complexed with an N-terminal peptide from the HIV-2 protease has been determined at 1.88A resolution. Interactions of the peptide with scFv1696 are compared with the previously reported structure of scFv1696 in complex with the corresponding peptide from HIV-1 protease. The origin of cross-reactivity of mAb1696 with HIV proteases is discussed.
==About this Structure==
==About this Structure==
-
1SVZ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1SVZ OCA].
+
1SVZ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1SVZ OCA].
==Reference==
==Reference==
Line 14: Line 13:
[[Category: Mus musculus]]
[[Category: Mus musculus]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Bentley, G.A.]]
+
[[Category: Bentley, G A.]]
[[Category: Brynda, J.]]
[[Category: Brynda, J.]]
[[Category: Fabry, M.]]
[[Category: Fabry, M.]]
Line 23: Line 22:
[[Category: antibody-antigen complex; hiv inhibiting antibody]]
[[Category: antibody-antigen complex; hiv inhibiting antibody]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov 8 14:29:27 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:05:51 2008''

Revision as of 13:05, 21 February 2008


1svz, resolution 1.89Å

Drag the structure with the mouse to rotate

Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-2 protease

Overview

The monoclonal antibody 1696, elicited by HIV-1 protease, inhibits the activity of both HIV-1 and HIV-2 proteases with inhibition constants in the low nanomolar range. The antibody cross-reacts with peptides derived from the N-terminal region of both proteases. The crystal structure of the recombinant single-chain Fv fragment of 1696 complexed with an N-terminal peptide from the HIV-2 protease has been determined at 1.88A resolution. Interactions of the peptide with scFv1696 are compared with the previously reported structure of scFv1696 in complex with the corresponding peptide from HIV-1 protease. The origin of cross-reactivity of mAb1696 with HIV proteases is discussed.

About this Structure

1SVZ is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.

Reference

Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide., Rezacova P, Brynda J, Lescar J, Fabry M, Horejsi M, Sieglova I, Sedlacek J, Bentley GA, J Struct Biol. 2005 Mar;149(3):332-7. PMID:15721587

Page seeded by OCA on Thu Feb 21 15:05:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools